Industry

RevolKa Ltd. Secures 210 million JPY (US$1.4 million) Series A Extension Funding to Advance Therapeutic Programs

RevolKa gearing up AI-powered protein engineering to deliver novel therapeutics and engineered proteins SENDAI, Japan–(BUSINESS WIRE)–RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein®, has raised 210 million JPY (US$1.4M) in Series A extension funding. This funding will advance RevolKa’s drug discovery programs for rare diseases (https://www.revolka.com/news/english/collab-en/a65) … [Read more…]

Curebound Concert for Cures with Elton John Raises $11.5 Million at Largest and Highest Grossing Fundraiser for Cancer Research in San Diego’s History

Twenty-seven thousand people united to fight cancer, fueling hope and discovery through record-setting attendance and fundraising SAN DIEGO–(BUSINESS WIRE)–#ConcertforCures—Curebound announced today that its 2025 Concert for Cures with global music icon and humanitarian Elton John raised $11.5 million in support of cancer research. The benefit concert, held at Petco Park, marks the largest and most … [Read more…]

VA Partners with Televeda to Expand Suicide Prevention Solution for Indigenous Veterans

PHOENIX–(BUSINESS WIRE)–Televeda, a community engagement platform dedicated to reducing social isolation and loneliness, has been awarded a contract by the U.S. Department of Veterans Affairs (VA) to pilot and expand its Hero’s Story Project (HSP), a culturally tailored suicide prevention program designed specifically for American Indian and Alaska Native (AIAN) veterans. The Hero’s Story Project … [Read more…]

Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma

AIRSUPRA demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone Full results published in the New England Journal of Medicine and presented at ATS 2025 International Conference WILMINGTON, Del.–(BUSINESS WIRE)–Positive full results from the BATURA Phase IIIb trial showed AstraZeneca’s anti-inflammatory reliever rescue therapy, AIRSUPRA (albuterol/budesonide), demonstrated … [Read more…]

High SCA Treatment Rates Despite Contemporary GDMT in 19,000+ Consecutive LifeVest® Patient Study

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced results from SCD-PROTECT, a nationwide analysis of LifeVest® wearable cardioverter defibrillator (WCD) patients … [Read more…]

Genethon Presents Two Year Consolidated Results of Its Gene Therapy Trial for Duchenne Muscular Dystrophy: Maintenance of Motor Functions and Significant, Sustained Reduction in CPK Levels in Patients Treated at the Effective Dose at ASGCT 2025

GNT0004 product confirms its clinical efficacy with stabilization of motor functions in patients treated at the effective dose for up to 2 years. Sustained significant reduction in levels of creatine phosphokinase (CPK), a biomarker of muscle damage, with an average decrease of over 75% at 18 months in the 3 patients treated at the effective … [Read more…]

Jason Hancock Joins BioRewards as Head of IT and Digital Operations, Advancing Tech-Driven Plasma Supply Experience

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#BiotechStartup—BioRewards Plasma Services (“BioRewards”), a next-generation U.S.-based plasma collection network, is pleased to announce that Jason Hancock has joined the company as Head of IT and Digital Operations. Hancock brings over two decades of healthcare technology leadership, most recently serving as Senior Director of IT at one of the world’s top four global … [Read more…]

RIIG Expands Presence in Middle East With New Round of Funding

Visit Coincides with Company Rebrand to Humans Out of the Loop (HOOTL) DUBAI, United Arab Emirates & CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–#AI–RIIG, a risk intelligence and cybersecurity solutions provider, is pleased to announce it has closed on a significant round of funding from investors in the United Arab Emirates (UAE). This new funding will help propel the … [Read more…]

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Technology Unit

WASHINGTON & BERLIN–(BUSINESS WIRE)–Association of Medical Device Reprocessors issued the following statement: Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws … [Read more…]

Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic Society Conference (ATS) 2025

LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP and demonstrated that molgramostim reduces surfactant burden and improves health-related … [Read more…]